However, our clinical data demonstrating OPN’s upregulation in metastatic recurrent tumors, association with macrophage infiltration, and correlation with decreased relapse-free survival argue that OPN’s involvement in recurrence is neither restricted to integrin modulation nor breast cancer alone. The gene discussed is SPP1; the disease is breast carcinoma.